CAR can inhibit the proliferation and migration of tumor cells by inhibiting the expression of NF-κB, subsequently enhancing the oxidative phosphorylation level of mitochondria, increasing the accumulation of ROS in tumor cells, inducing cell cycle arrest and apoptosis (Jin et al., 2019). Here, NFKB1 is linked to neoplasm.